PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
July 26, 2012 | ISSUE NUMBER 261 VOL 8

Strategy
Innovative Contracting: What's the Verdict?
Industry is finding it harder to secure market access and payer uptake for new products. Innovative contracting may offer a solution. But is it working? Andrea Sobrio reports  ...Read more

Approvals
2012: Year of the Diet Pill
With June’s FDA approval of a weight-loss pill for the first time in more than 10 years, and a second approval following in July, this year appears to be the year of the diet pill, writes Amy Ritter ...Read More

Advertisement
On Demand Webcast
US Supreme Court Ruling On The Affordable Care Act: Implications For Your Business
Register Free at www.pharmexec.com/supremecourt

Europe
GSK Goes DTC for London Olympics
It’s an unusual sight in the UK — a television commercial for a Big Pharma company. But among the cultural and commercial innovations being attributed to the London Olympic Games is GSK’s first UK consumer-facing corporate brand campaign ...Read More

Event
Missed Opportunities in Rare Disease
At CBI’s 7th Annual Rare Disease and Orphan Drug Leadership Congress, speakers and attendees identified areas where pharma can improve the way it approaches rare disease and treatment
...Read more

Sales
Building Intelligence into Sales Force Alignment
Without effective field force alignment planning and day-to-day management, pharma companies will struggle to cost effectively and efficiently adapt to an increasingly challenging marketplace, writes Jitesh Rohatgi
...Read more

// Industry veteran Jack Bilson, III joined M3 USA (Washington, DC) as Vice President, Product Innovation. // Array BioPharma (Boulder, CO) appointed Andrew Robbins as Senior Vice President of Commercial Operations. // Pinstripe Healthcare (Brookfield, WI) announced that President Jill Schwieters will be joining the Advisory Board of the Women Business Leaders of the U.S. Health Care Industry Foundation. // Cubist Pharmaceuticals, Inc. (Lexington, MA) named Robert J. Perez, former Executive Vice President and Chief Operating Officer, as President and COO, and Michael Tomsicek, former Vice President of Corporate Finance, as Senior Vice President and Deputy Chief Financial Officer. The company also appointed Thomas Rollins as Senior Vice President of Program and Portfolio Management.

Augusts 14–16: 6th Annual Forum on Sunshine and Aggregate Spend
Washington, DC


September 20–21: 3rd Annual Forum on Strategic Distribution Planning for Specialty Products
East Brunswick, New Jersey


October 17–18: 2nd Annual Global Transparency Reporting Congress
Amsterdam, The Netherlands

Advertisement
Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch
On-Demand Webcast
http://pharmexec.com/demand

 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook


Survey
Into which pharmerging market — aside from China and India — is your company most interested in expanding?

Click To Vote
 
Quick Links

Pharm Exec's Emerging Pharma Leaders 2012

Paring the Fat in Clinical Trials

What is "Big Data" and How Should We Use it?


User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |